1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT00929110 · COMPLETED
Trial details
- NCT number
- NCT00929110
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2011-04-01
- Enrollment
- 1066
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.